August 5, 2024 by Julie Grisham, Memorial Sloan Kettering Cancer Center Credit: CC0 Public DomainThe U.S. Food and Drug Administration (FDA) has granted accelerated approval for the immunotherapy afamitresgene autoleuecel (Tecelra, also known as afami-cel) for the treatment of adults with a rare soft tissue cancer called synovial sarcoma. Afami-cel is the first engineered T...
Sydney researchers are testing whether an existing medication could be repurposed to treat sarcoma. Recruitment is now open for a national clinical trial that will test whether an existing therapy for psoriasis can help treat patients with sarcomas, which are rare cancers arising in the connective tissues (bone, muscle, tendons, nerves, fat, cartilage and blood vessels) and...
